{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:49:32Z","timestamp":1782485372367,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004829","name":"Science & Technology Department of Sichuan Province","doi-asserted-by":"crossref","award":["2023YFS0257"],"award-info":[{"award-number":["2023YFS0257"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05008-4","type":"journal-article","created":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T07:32:01Z","timestamp":1768116721000},"page":"2355-2364","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative efficacy of hyperthermic chemotherapy and BCG instillation in non-muscle invasive bladder cancer: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"58","author":[{"given":"Yucong","family":"Chai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YinXiong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhe","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,11]]},"reference":[{"key":"5008_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41585-024-00914-7","volume":"22","author":"M Olislagers","year":"2025","unstructured":"Olislagers M, de Jong FC, Rutten VC, Boormans JL, Mahmoudi T, Zuiverloon TCM (2025) Molecular biomarkers of progression in non-muscle-invasive bladder cancer - beyond conventional risk stratification. Nat Rev Urol 22:75\u201391","journal-title":"Nat Rev Urol"},{"key":"5008_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055782","volume":"11","author":"FZ Arthuso","year":"2021","unstructured":"Arthuso FZ, Fairey AS, Boul\u00e9 NG, Courneya KS (2021) Bladder cancer and exeRcise trAining during intraVesical thErapy-the BRAVE trial: a study protocol for a prospective, single-centre, phase II randomised controlled trial. BMJ Open 11:e055782","journal-title":"BMJ Open"},{"key":"5008_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","volume":"19","author":"JY Teoh","year":"2022","unstructured":"Teoh JY, Kamat AM, Black PC, Grivas P, Shariat SF, Babjuk M (2022) Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective. Nat Rev Urol 19:280\u2013294","journal-title":"Nat Rev Urol"},{"key":"5008_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.778973","volume":"12","author":"C Tang","year":"2021","unstructured":"Tang C, Liu H, Fan Y et al (2021) Functional nanomedicines for targeted therapy of bladder cancer. Front Pharmacol 12:778973","journal-title":"Front Pharmacol"},{"key":"5008_CR5","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.21037\/tcr-20-758","volume":"9","author":"J Suh","year":"2020","unstructured":"Suh J, Yoo S (2020) Role of immunotherapy in Bacillus Calmette-Gu\u00e9rin unresponsive: non-muscle invasive bladder cancer. Transl Cancer Res 9:6537\u20136545","journal-title":"Transl Cancer Res"},{"key":"5008_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10616-022-00559-7","volume":"75","author":"T Uehara","year":"2023","unstructured":"Uehara T, Watanabe S, Yamaguchi S et al (2023) Translocation of nuclear chromatin distribution to the periphery reflects dephosphorylated threonine-821\/826 of the retinoblastoma protein (pRb) in T24 cells treated with Bacillus Calmette-Gu\u00e9rin. Cytotechnology 75:49\u201362","journal-title":"Cytotechnology"},{"key":"5008_CR7","volume":"36","author":"LS Low","year":"2021","unstructured":"Low LS, Scholtz D, Leyland J, Nair SM (2021) A severe complication of intravesical bacillus Calmette-Guerin: an effect of different strains. Urol Case Rep 36:101592","journal-title":"Urol Case Rep"},{"key":"5008_CR8","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2024.5704","author":"T Tsai","year":"2024","unstructured":"Tsai T, Hwang TI, Chen P et al (2024) Hyperthermia reduces cancer cell invasion and combats chemoresistance and immune evasion in human bladder cancer. Int J Oncol. https:\/\/doi.org\/10.3892\/ijo.2024.5704","journal-title":"Int J Oncol"},{"key":"5008_CR9","doi-asserted-by":"publisher","first-page":"62.e13","DOI":"10.1016\/j.urolonc.2021.07.019","volume":"40","author":"OM Pijpers","year":"2022","unstructured":"Pijpers OM, Hendricksen K, Mostafid H et al (2022) Long-term efficacy of hyperthermic intravesical chemotherapy for BCG-unresponsive non-muscle invasive bladder cancer. Urol Oncol 40:62.e13-62.e20","journal-title":"Urol Oncol"},{"key":"5008_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-025-01773-z","volume":"25","author":"Z Huang","year":"2025","unstructured":"Huang Z, Huang S, Wu E, He Q, Wei X, Liang W (2025) Comparison of hyperthermic intravesical chemotherapy using pirarubicin and Bacillus Calmette-Gu\u00e9rin in the treatment of patients with high-risk non-muscle-invasive bladder carcinoma: a retrospective study. BMC Urol 25:81","journal-title":"BMC Urol"},{"key":"5008_CR11","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s11255-023-03849-x","volume":"56","author":"Y Pazir","year":"2024","unstructured":"Pazir Y, Esmeray A, Caglar U et al (2024) Comparison of hyperthermic intravesical chemotherapy and Bacillus Calmette-Guerin therapy in high-risk non-muscle invasive bladder cancer: A matched-pair analysis. Int Urol Nephrol 56:957\u2013963","journal-title":"Int Urol Nephrol"},{"key":"5008_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: Explanation and elaboration. BMJ 339:b2700","journal-title":"BMJ"},{"key":"5008_CR13","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00345-022-03928-1","volume":"40","author":"F Guerrero-Ramos","year":"2022","unstructured":"Guerrero-Ramos F, Gonz\u00e1lez-Padilla DA, Gonz\u00e1lez-D\u00edaz A et al (2022) Recirculating hyperthermic intravesical chemotherapy with mitomycin C (HIVEC) versus BCG in high-risk non-muscle-invasive bladder cancer: results of the HIVEC-HR randomized clinical trial. World J Urol 40:999\u20131004","journal-title":"World J Urol"},{"key":"5008_CR14","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00345-024-05338-x","volume":"42","author":"A Sachan","year":"2024","unstructured":"Sachan A, Nayyar R, Pethe S, Singh P, Seth A (2024) A 3-arm randomized control trial to compare the efficacy of re-circulant hyperthermic intravesical chemotherapy versus conventional intravesical mitomycin C and BCG therapy for intermediate-risk non-muscle invasive bladder cancer. World J Urol 42:609","journal-title":"World J Urol"},{"key":"5008_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.eururo.2018.09.005","volume":"75","author":"WS Tan","year":"2019","unstructured":"Tan WS, Panchal A, Buckley L et al (2019) Radiofrequency-induced thermo-chemotherapy effect versus a second course of bacillus Calmette-Gu\u00e9rin or institutional standard in patients with recurrence of non-muscle-invasive bladder cancer following induction or maintenance bacillus Calmette-Gu\u00e9rin therapy (HYMN): A phase III, open-label, randomised controlled trial. Eur Urol 75:63\u201371","journal-title":"Eur Urol"},{"key":"5008_CR16","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.eururo.2016.01.006","volume":"69","author":"TJH Arends","year":"2016","unstructured":"Arends TJH, Nativ O, Maffezzini M et al (2016) Results of a randomised controlled trial comparing intravesical chemohyperthermia with mitomycin c versus bacillus Calmette-Gu\u00e9rin for adjuvant treatment of patients with intermediate- and high-risk Non-Muscle-invasive bladder cancer. Eur Urol 69:1046\u20131052","journal-title":"Eur Urol"},{"key":"5008_CR17","doi-asserted-by":"publisher","first-page":"E278","DOI":"10.5489\/cuaj.2708","volume":"9","author":"RG Ekin","year":"2015","unstructured":"Ekin RG, Akarken I, Zorlu F et al (2015) Intravesical bacillus Calmette-Gu\u00e9rin versus chemohyperthermia for high-risk non-muscle-invasive bladder cancer. Can Urol Assoc J 9:E278\u2013E283","journal-title":"Can Urol Assoc J"},{"key":"5008_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci14121203","author":"M Elmasri","year":"2024","unstructured":"Elmasri M, Clark A, Grundy L (2024) Peripheral mechanisms underlying bacillus Calmette-Guerin-induced lower urinary tract symptoms (LUTS). Brain Sci. https:\/\/doi.org\/10.3390\/brainsci14121203","journal-title":"Brain Sci"},{"key":"5008_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1327053","volume":"17","author":"G Bourlotos","year":"2023","unstructured":"Bourlotos G, Baigent W, Hong M, Plagakis S, Grundy L (2023) BCG induced lower urinary tract symptoms during treatment for NMIBC-mechanisms and management strategies. Front Neurosci 17:1327053","journal-title":"Front Neurosci"},{"key":"5008_CR20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.4103\/UA.UA_139_20","volume":"13","author":"YB Thyavihally","year":"2021","unstructured":"Thyavihally YB, Waigankar SS, Dev P et al (2021) Comparing adverse effects, short term outcomes, and cost implications of hyperthermic intravesical chemotherapy with Mitomycin-C and intravesical bacillus Calmette-Guerin instillation (Moscow-I strain) in the management of intermediate and high-risk nonmuscle invasive bladder cancer. Urol Ann 13:424\u2013430","journal-title":"Urol Ann"},{"key":"5008_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1164932","volume":"13","author":"N Zeng","year":"2023","unstructured":"Zeng N, Xu M, Sun J et al (2023) Hyperthermia intravesical chemotherapy acts as a promising alternative to bacillus Calmette-Gu\u00e9rin instillation in non-muscle-invasive bladder cancer: a network meta-analysis. Front Oncol 13:1164932","journal-title":"Front Oncol"},{"key":"5008_CR22","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1080\/02656736.2021.2002435","volume":"38","author":"L Doisy","year":"2021","unstructured":"Doisy L, Cimier A, Adypagavane A et al (2021) Efficacy of HIVEC in patients with high-risk non-muscle invasive bladder cancer who are contraindicated to BCG and in patients who fail BCG therapy. Int J Hyperthermia 38:1633\u20131638","journal-title":"Int J Hyperthermia"},{"key":"5008_CR23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/21681805.2021.1938664","volume":"55","author":"JA Thomsen","year":"2021","unstructured":"Thomsen JA, Nielsen Dominiak H, Lindgren MS, Jensen JB (2021) Adverse events of hyperthermic intravesical chemotherapy for non-muscle invasive bladder cancer patients. Scand J Urol 55:281\u2013286","journal-title":"Scand J Urol"},{"key":"5008_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03605-y","volume":"12","author":"X Li","year":"2021","unstructured":"Li X, Zheng J, Chen S, Meng F, Ning J, Sun S (2021) Oleandrin, a cardiac glycoside, induces immunogenic cell death via the PERK\/elF2\u03b1\/ATF4\/CHOP pathway in breast cancer. Cell Death Dis 12:314","journal-title":"Cell Death Dis"},{"key":"5008_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/02656736.2018.1492027","volume":"35","author":"K Ando","year":"2018","unstructured":"Ando K, Suzuki Y, Kaminuma T et al (2018) Tumor-specific CD8-positive T cell-mediated antitumor immunity is implicated in the antitumor effect of local hyperthermia. Int J Hyperthermia 35:226\u2013231","journal-title":"Int J Hyperthermia"},{"key":"5008_CR26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.20892\/j.issn.2095-3941.2020.0125","volume":"18","author":"Q Ruan","year":"2021","unstructured":"Ruan Q, Ding D, Wang B et al (2021) A multi-institutional retrospective study of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone in intermediate and high risk nonmuscle-invasive bladder cancer. Cancer Biol Med 18:308\u2013317","journal-title":"Cancer Biol Med"},{"key":"5008_CR27","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/j.jval.2023.08.008","volume":"26","author":"M Serra-Burriel","year":"2023","unstructured":"Serra-Burriel M, Aebersold H, Foster-Witassek F et al (2023) Real-world cost-effectiveness of pulmonary vein isolation for atrial fibrillation: a target trial approach. Value Health 26:1721\u20131729","journal-title":"Value Health"},{"key":"5008_CR28","volume":"15","author":"AA Alsaati","year":"2023","unstructured":"Alsaati AA, Alsaadoun D, Kinkar LI, Alkhamis RS, Ahmed WA, Almathami AH (2023) The efficacy and safety of botulinum toxin A for the treatment of rosacea: a systematic review. Cureus 15:e51304","journal-title":"Cureus"},{"key":"5008_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264005","volume":"17","author":"A Berhane","year":"2022","unstructured":"Berhane A, Belachew T (2022) Trend and burden of neural tube defects among cohort of pregnant women in Ethiopia: where are we in the prevention and what is the way forward? PLoS ONE 17:e0264005","journal-title":"PLoS ONE"},{"key":"5008_CR30","doi-asserted-by":"publisher","first-page":"491","DOI":"10.47102\/annals-acadmedsg.202560","volume":"54","author":"HP Ng","year":"2025","unstructured":"Ng HP, Zhong LL, Peh WWL, Lam WC, Mak K, Lim S (2025) Integrating traditional Chinese medicine into disease management in Singapore. Ann Acad Med Singap 54:491\u2013497","journal-title":"Ann Acad Med Singap"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05008-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05008-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05008-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:18:56Z","timestamp":1782483536000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05008-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,11]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["5008"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05008-4","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,11]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}